|Articles|January 21, 2021
Operational Impact of Annex 1 Update
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
2
Regulatory Expectations for Evaluating GMP Facilities and Equipment
3
Trends and Challenges Impacting Highly Potent API Development
4
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
5
